Guanxin Danshen Dripping Pills Improve Quality of Life and Cardiovascular Prognoses of CHD Patients after PCI with Anxiety or Depression (GLAD Study): A Randomized Double-Blind Placebo-Controlled Study-Reference-Cited by-同舟云学术

Guanxin Danshen Dripping Pills Improve Quality of Life and Cardiovascular Prognoses of CHD Patients after PCI with Anxiety or Depression (GLAD Study): A Randomized Double-Blind Placebo-Controlled Study

Published:2022-10-27 Issue:3 Volume:29 Page:195-204
ISSN:1672-0415
Container-title:Chinese Journal of Integrative Medicine
language:en
Short-container-title:Chin. J. Integr. Med.

Author:

Wang Cheng-long,Huan Na,Wang Pei-li,Geng Qing-shan,Ma Wen-lin,Ma Li-hong,Jiang Hong-yan,Meng Xiao-ping,Zhang Da-wu,Gou Xiao-jiang,Hu Da-yi,Chen Ke-ji

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Complementary and alternative medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11655-022-3688-3.pdf

Reference46 articles.

1. Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke statistics—2022 update: a report from the American Heart Association. Circulation 2022;145:e153–e639.

2. Jha MK, Qamar A, Vaduganathan M, Charney DS, Murrough JW. Screening and management of depression in patients with cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol 2019;73:1827–1845.

3. Olsen SJ, Schirmer H, Wilsgaard T, Bønaa KH, Hanssen TA. Cardiac rehabilitation and symptoms of anxiety and depression after percutaneous coronary intervention. Eur J Prev Cardiol 2018;25:1017–1025.

4. Pogosova N, Kotseva K, De Bacquer D, von Känel R, De Smedt D, Bruthans J, et al. EUROASPIRE Investigators. Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: results from the EUROASPIRE IV survey. a registry from the European Society of Cardiology. Eur J Prev Cardiol 2017;24:1371–1380.

5. De Bacquer D, De Smedt D, Kotseva K, Jennings C, Wood D, Rydén L, et al. Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study. Eur J Epidemiol 2019;34:247–258.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Status and Trends of Traditional Chinese Medicine Therapeutic Formulae for Coronary Heart Disease Scientometrics Research;International Journal of General Medicine;2024-03

2. Traditional Chinese Medicine for Cardiovascular Disease: Efficacy and Safety;2024